nigericin has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; Dong, T; Gao, J; Huang, W; Pan, W; Wang, W; Yao, S; Zhang, S; Zhao, Y | 1 |
| Barenholz, Y; Gabizon, AA; Horowitz, AT | 1 |
| Albright, KD; Andrews, PA | 1 |
3 other study(ies) available for nigericin and Cancer of Ovary
| Article | Year |
|---|---|
Nigericin Inhibits Epithelial Ovarian Cancer Metastasis by Suppressing the Cell Cycle and Epithelial-Mesenchymal Transition.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; G1 Phase Cell Cycle Checkpoints; Humans; Microscopy, Fluorescence; Neoplasms, Glandular and Epithelial; Nigericin; Ovarian Neoplasms; Wnt Signaling Pathway | 2017 |
In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release.
Topics: Cell Division; Doxorubicin; Female; Humans; Kinetics; Liposomes; Nigericin; Ovarian Neoplasms; Tumor Cells, Cultured | 1992 |
Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line; Cell Membrane; Cisplatin; Drug Resistance; Female; Fluorescent Dyes; Humans; Kinetics; Membrane Potentials; Microscopy, Electron; Microscopy, Fluorescence; Mitochondria; Nigericin; Onium Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Rhodamine 123; Rhodamines | 1992 |